SCHEMBL6651796

SCHEMBL6651796

CNC(=N)NC(=O)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
KMT2A Q03164 3/20 0.48
MEN1 O00255 2/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
HDAC8 Q9BY41 3/20 0.48
HDAC6 Q9UBN7 3/20 0.48
HDAC2 Q92769 2/20 0.48
HDAC3 O15379 1/20 0.48
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48
IDO1 P14902 1/20 0.48
ALOX15 P16050 1/20 0.48
HDAC1 Q13547 1/20 0.48
CA9 Q16790 1/20 0.48
HDAC7 Q8WUI4 1/20 0.48
HSD17B10 Q99714 1/20 0.48
NCOR2 Q9Y618 1/20 0.48
EPHX1 P07099 3/20 0.47
KDM4E B2RXH2 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6933112 0.87 ALDH1A1 (0.57) ALDH1A1KMT2AMEN1NPC1RAB9A
SCHEMBL6100 0.83 HDAC8 (0.62) ALDH1A1KMT2AMEN1NPC1RAB9A
SCHEMBL7124393 0.82 RAB9A (0.55) ALDH1A1KMT2AMEN1NPC1RAB9A
SCHEMBL7129356 0.82 ALDH1A1 (0.54) ALDH1A1KMT2AMEN1NPC1RAB9A
SCHEMBL25489176 0.81 HDAC8 (0.61) ALDH1A1KMT2AMEN1NPC1RAB9A
Methane SCHEMBL15893673 0.81 HDAC8 (0.67) ALDH1A1KMT2AMEN1NPC1RAB9A
Hydrochloric Acid SCHEMBL2915137 0.81 HDAC8 (0.60) ALDH1A1KMT2AMEN1NPC1RAB9A
SCHEMBL7796539 0.81 HDAC8 (0.60) ALDH1A1KMT2AMEN1NPC1RAB9A
Hydrochloric Acid SCHEMBL5075431 0.81 HDAC8 (0.60) ALDH1A1KMT2AMEN1NPC1RAB9A
SCHEMBL11130438 0.81 HDAC8 (0.60) ALDH1A1KMT2AMEN1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1427419-A1 IMPROVEMENT OF THE LOCAL COMPATIBILITY DURING INTRAVENOUS ADMINISTRATION OF 4-(4-(2-PYRROLYLCARBONYL)-1-PIPERAZINYL)-3-TRIFLUORMETHYL-BENZOYLGUANIDINE Boehringer Ingelheim Pharma GmbH & Co.KG (DE) 2004-06-16 EP claimed
WO-2003022281-A1 IMPROVEMENT OF THE LOCAL COMPATIBILITY DURING INTRAVENOUS ADMINISTRATION OF 4-(4-(2-PYRROLYLCARBONYL)-1-PIPERAZINYL)-3-TRIFLUORMETHYL-BENZOYLGUANIDINE BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2003-03-20 WO claimed
US-6667356-B2 Including an n-amidinobenzamide derivative; heat aging resistance BRIDGESTONE CORPORATION (JP) 2003-12-23 US disclosed
US-20030134947-A1 Containing imine, amidine or guanidine antioxidants to improve heat aging resistance; may be substituted by acyl, thioacyl or additional imine groups BRIDGESTONE CORPORATION, OTSUKA CHEMICAL CO., LTD. 2003-07-17 US disclosed
US-6515055-B1 Excellent in heat aging resistance due to addition of compounds exemplified by N'-(N-benzoylamidino) benzoic acid hydrazide BRIDGESTONE CORPORATION (JP) 2003-02-04 US disclosed
EP-1101793-A1 Heat ageing resistant rubber composition Bridgestone Corporation (JP) 2001-05-23 EP disclosed